HomeHealth

Health

iBio Acquires RubrYc Therapeutics’ AI Drug Discovery Platform and Pipeline

iBio Acquires RubrYc Therapeutics’ AI Drug Discovery Platform and Pipeline

September 22, 2022

Tonix Pharmaceuticals Presents Data from Retrospective Observational Database Study on the Incidence of Multi-Site Pain Symptoms in Long COVID Patients at IASP 2022 World Congress on Pain

Tonix Pharmaceuticals Presents Data from Retrospective Observational Database Study on the Incidence of Multi-Site Pain Symptoms in Long COVID Patients at IASP 2022 World Congress on Pain

September 22, 2022

The Forces of Beauty® Report from The DREAM Initiative® Reveals Demand for New Standards of Beauty and Imagery

The Forces of Beauty® Report from The DREAM Initiative® Reveals Demand for New Standards of Beauty and Imagery

September 22, 2022

CVS Health reports progress against goal to reduce suicide attempts among Aetna members 20% by 2025

CVS Health reports progress against goal to reduce suicide attempts among Aetna members 20% by 2025

September 22, 2022

Aurora Cannabis Announces Fiscal 2022 Fourth Quarter and Full Year Results

Aurora Cannabis Announces Fiscal 2022 Fourth Quarter and Full Year Results

September 21, 2022

Evoke Pharma Receives Notice of Allowance from USPTO for a Patent Related to GIMOTI

Evoke Pharma Receives Notice of Allowance from USPTO for a Patent Related to GIMOTI

September 21, 2022

The Fundación Instituto Valenciano de Oncología Leverages HTG Technology for Breast Cancer Laboratory-Developed Test

The Fundación Instituto Valenciano de Oncología Leverages HTG Technology for Breast Cancer Laboratory-Developed Test

September 21, 2022

John Hancock becomes the first life insurance carrier to offer access to GRAIL’s multi-cancer early detection test to customers

John Hancock becomes the first life insurance carrier to offer access to GRAIL’s multi-cancer early detection test to customers

September 21, 2022

Stryker receives FDA clearance for OptaBlate(TM) Bone Tumor Ablation System

Stryker receives FDA clearance for OptaBlate(TM) Bone Tumor Ablation System

September 21, 2022

Health Canada approves Takeda’s LIVTENCITY(TM) (maribavir) the First and Only Treatment for Adults with Post-Transplant Cytomegalovirus (CMV) infection

Health Canada approves Takeda’s LIVTENCITY(TM) (maribavir) the First and Only Treatment for Adults with Post-Transplant Cytomegalovirus (CMV) infection

September 21, 2022

« 1 … 97 98 99 100 101 … 123 »